skip to main content

DMARD monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMusculoskeletal TherapeuticsDMARD monitoringGPhC CRA

A patient taking sulfasalazine for rheumatoid arthritis asks why the surgery keeps arranging blood tests. He has been stable for two months after a dose increase. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: B — Full blood count and liver function tests at recommended intervals

Conventional DMARDs such as sulfasalazine require monitoring for blood dyscrasias and hepatotoxicity. Full blood count and liver function testing are part of routine safety monitoring, with frequency depending on stage of treatment and local shared-care guidance. Patients should report sore throat, fever, bruising or jaundice promptly.

Reference: NICE CKS; BNF